Valve Academic Research Consortium 2(English)

• primary safety endpoint measured at 30 days and defined according to a composite of all-cause death, stroke, life-threatening or disabling bleeding, stage 2–3 acute kidney injury, coronary artery obstruction requiring intervention, major vascular complications, and valve-related dysfunction requiring repeat procedure
• AKI, CEP, HDH, MoCA, NIHSS, SCIL
• Cardiology, Clinical trials, Prognosis
• https://doi.org…rheartj/ehab213